AAPL313.88+3.22 (+1.03%) ▲|ABBV252.90-1.76 (-0.69%) ▼|ABT95.12-0.72 (-0.75%) ▼|ACN137.19-4.96 (-3.49%) ▼|ADBE221.01-0.53 (-0.24%) ▼|AMAT570.53+16.03 (+2.89%) ▲|AMD517.41+1.30 (+0.25%) ▲|AMGN367.99-0.11 (-0.03%) ▼|AMT165.01-0.25 (-0.15%) ▼|AMZN243.62-2.36 (-0.96%) ▼|AVGO388.69+17.91 (+4.83%) ▲|AXP336.32-13.26 (-3.79%) ▼|BA224.83-6.85 (-2.96%) ▼|BAC58.32-1.55 (-2.58%) ▼|BKNG174.29-7.66 (-4.21%) ▼|BLK990.31-19.12 (-1.89%) ▼|BMY57.53-0.44 (-0.76%) ▼|BNY150.12-2.79 (-1.82%) ▼|BRK-B494.97-9.03 (-1.79%) ▼|C137.39-3.38 (-2.40%) ▼|CAT947.50+7.38 (+0.79%) ▲|CL93.04-1.99 (-2.09%) ▼|CMCSA23.19-0.22 (-0.94%) ▼|COF191.92-10.97 (-5.41%) ▼|COP110.70+2.26 (+2.08%) ▲|COST953.13+5.63 (+0.59%) ▲|CRM166.57-2.95 (-1.74%) ▼|CSCO113.82+2.03 (+1.82%) ▲|CVS104.44+0.11 (+0.11%) ▲|CVX175.92+1.91 (+1.10%) ▲|DE596.58-7.03 (-1.16%) ▼|DHR190.65-3.55 (-1.83%) ▼|DIS96.71-0.77 (-0.79%) ▼|DUK126.79-1.43 (-1.12%) ▼|EMR136.50-1.41 (-1.02%) ▼|FDX309.68-3.20 (-1.02%) ▼|GD374.32-0.32 (-0.09%) ▼|GE355.96-11.02 (-3.00%) ▼|GEV1,071.30-5.78 (-0.54%) ▼|GILD135.82-0.54 (-0.40%) ▼|GM76.23+0.20 (+0.26%) ▲|GOOG358.71-4.91 (-1.35%) ▼|GOOGL361.92-5.11 (-1.39%) ▼|GS1,029.18-13.81 (-1.32%) ▼|HD336.20-9.01 (-2.61%) ▼|HON220.36-4.69 (-2.08%) ▼|IBM301.92-4.21 (-1.38%) ▼|INTC110.24-0.15 (-0.14%) ▼|INTU272.10-9.07 (-3.23%) ▼|ISRG415.10-12.20 (-2.86%) ▼|JNJ263.35-3.89 (-1.46%) ▼|JPM330.52-8.70 (-2.56%) ▼|KO83.40-0.65 (-0.77%) ▼|LIN527.67-10.56 (-1.96%) ▼|LLY1,215.84-19.72 (-1.60%) ▼|LMT527.94-7.44 (-1.39%) ▼|LOW212.77-8.13 (-3.68%) ▼|LRCX333.15+7.02 (+2.15%) ▲|MA519.88-11.75 (-2.21%) ▼|MCD278.27-3.94 (-1.40%) ▼|MDLZ59.48-0.74 (-1.23%) ▼|MDT82.00-1.84 (-2.19%) ▼|META603.12-12.46 (-2.02%) ▼|MMM154.74-3.27 (-2.07%) ▼|MO72.79-0.17 (-0.23%) ▼|MRK125.99-2.87 (-2.23%) ▼|MS218.13-3.92 (-1.76%) ▼|MSFT383.34-5.50 (-1.41%) ▼|MU948.80+10.42 (+1.11%) ▲|NEE87.43-1.04 (-1.18%) ▼|NFLX75.59-0.59 (-0.77%) ▼|NKE42.88-0.33 (-0.76%) ▼|NOW107.78-2.96 (-2.67%) ▼|NVDA204.12+7.19 (+3.65%) ▲|ORCL140.57-1.04 (-0.73%) ▼|PEP142.50-2.49 (-1.71%) ▼|PFE24.04-0.03 (-0.12%) ▼|PG148.40-4.36 (-2.85%) ▼|PLTR132.22-2.15 (-1.60%) ▼|PM187.09-0.71 (-0.38%) ▼|QCOM186.56+3.59 (+1.96%) ▲|RTX194.90-5.96 (-2.96%) ▼|SBUX103.87+0.26 (+0.25%) ▲|SCHW101.69-0.24 (-0.24%) ▼|SO96.38-0.91 (-0.94%) ▼|SPG219.15-8.05 (-3.54%) ▼|T21.07-0.03 (-0.12%) ▼|TMO509.87-6.75 (-1.31%) ▼|TMUS180.14-4.59 (-2.48%) ▼|TSLA393.93-8.97 (-2.23%) ▼|TXN301.32+8.02 (+2.73%) ▲|UBER73.59-0.75 (-1.00%) ▼|UNH425.54-2.65 (-0.62%) ▼|UNP280.96-2.16 (-0.76%) ▼|UPS109.91-2.06 (-1.84%) ▼|USB60.99-1.90 (-3.02%) ▼|V347.52-4.68 (-1.33%) ▼|VZ42.45-0.14 (-0.33%) ▼|WFC85.57-1.61 (-1.85%) ▼|WMT113.10+1.56 (+1.40%) ▲|XOM140.95-0.75 (-0.53%) ▼|AAPL313.88+3.22 (+1.03%) ▲|ABBV252.90-1.76 (-0.69%) ▼|ABT95.12-0.72 (-0.75%) ▼|ACN137.19-4.96 (-3.49%) ▼|ADBE221.01-0.53 (-0.24%) ▼|AMAT570.53+16.03 (+2.89%) ▲|AMD517.41+1.30 (+0.25%) ▲|AMGN367.99-0.11 (-0.03%) ▼|AMT165.01-0.25 (-0.15%) ▼|AMZN243.62-2.36 (-0.96%) ▼|AVGO388.69+17.91 (+4.83%) ▲|AXP336.32-13.26 (-3.79%) ▼|BA224.83-6.85 (-2.96%) ▼|BAC58.32-1.55 (-2.58%) ▼|BKNG174.29-7.66 (-4.21%) ▼|BLK990.31-19.12 (-1.89%) ▼|BMY57.53-0.44 (-0.76%) ▼|BNY150.12-2.79 (-1.82%) ▼|BRK-B494.97-9.03 (-1.79%) ▼|C137.39-3.38 (-2.40%) ▼|CAT947.50+7.38 (+0.79%) ▲|CL93.04-1.99 (-2.09%) ▼|CMCSA23.19-0.22 (-0.94%) ▼|COF191.92-10.97 (-5.41%) ▼|COP110.70+2.26 (+2.08%) ▲|COST953.13+5.63 (+0.59%) ▲|CRM166.57-2.95 (-1.74%) ▼|CSCO113.82+2.03 (+1.82%) ▲|CVS104.44+0.11 (+0.11%) ▲|CVX175.92+1.91 (+1.10%) ▲|DE596.58-7.03 (-1.16%) ▼|DHR190.65-3.55 (-1.83%) ▼|DIS96.71-0.77 (-0.79%) ▼|DUK126.79-1.43 (-1.12%) ▼|EMR136.50-1.41 (-1.02%) ▼|FDX309.68-3.20 (-1.02%) ▼|GD374.32-0.32 (-0.09%) ▼|GE355.96-11.02 (-3.00%) ▼|GEV1,071.30-5.78 (-0.54%) ▼|GILD135.82-0.54 (-0.40%) ▼|GM76.23+0.20 (+0.26%) ▲|GOOG358.71-4.91 (-1.35%) ▼|GOOGL361.92-5.11 (-1.39%) ▼|GS1,029.18-13.81 (-1.32%) ▼|HD336.20-9.01 (-2.61%) ▼|HON220.36-4.69 (-2.08%) ▼|IBM301.92-4.21 (-1.38%) ▼|INTC110.24-0.15 (-0.14%) ▼|INTU272.10-9.07 (-3.23%) ▼|ISRG415.10-12.20 (-2.86%) ▼|JNJ263.35-3.89 (-1.46%) ▼|JPM330.52-8.70 (-2.56%) ▼|KO83.40-0.65 (-0.77%) ▼|LIN527.67-10.56 (-1.96%) ▼|LLY1,215.84-19.72 (-1.60%) ▼|LMT527.94-7.44 (-1.39%) ▼|LOW212.77-8.13 (-3.68%) ▼|LRCX333.15+7.02 (+2.15%) ▲|MA519.88-11.75 (-2.21%) ▼|MCD278.27-3.94 (-1.40%) ▼|MDLZ59.48-0.74 (-1.23%) ▼|MDT82.00-1.84 (-2.19%) ▼|META603.12-12.46 (-2.02%) ▼|MMM154.74-3.27 (-2.07%) ▼|MO72.79-0.17 (-0.23%) ▼|MRK125.99-2.87 (-2.23%) ▼|MS218.13-3.92 (-1.76%) ▼|MSFT383.34-5.50 (-1.41%) ▼|MU948.80+10.42 (+1.11%) ▲|NEE87.43-1.04 (-1.18%) ▼|NFLX75.59-0.59 (-0.77%) ▼|NKE42.88-0.33 (-0.76%) ▼|NOW107.78-2.96 (-2.67%) ▼|NVDA204.12+7.19 (+3.65%) ▲|ORCL140.57-1.04 (-0.73%) ▼|PEP142.50-2.49 (-1.71%) ▼|PFE24.04-0.03 (-0.12%) ▼|PG148.40-4.36 (-2.85%) ▼|PLTR132.22-2.15 (-1.60%) ▼|PM187.09-0.71 (-0.38%) ▼|QCOM186.56+3.59 (+1.96%) ▲|RTX194.90-5.96 (-2.96%) ▼|SBUX103.87+0.26 (+0.25%) ▲|SCHW101.69-0.24 (-0.24%) ▼|SO96.38-0.91 (-0.94%) ▼|SPG219.15-8.05 (-3.54%) ▼|T21.07-0.03 (-0.12%) ▼|TMO509.87-6.75 (-1.31%) ▼|TMUS180.14-4.59 (-2.48%) ▼|TSLA393.93-8.97 (-2.23%) ▼|TXN301.32+8.02 (+2.73%) ▲|UBER73.59-0.75 (-1.00%) ▼|UNH425.54-2.65 (-0.62%) ▼|UNP280.96-2.16 (-0.76%) ▼|UPS109.91-2.06 (-1.84%) ▼|USB60.99-1.90 (-3.02%) ▼|V347.52-4.68 (-1.33%) ▼|VZ42.45-0.14 (-0.33%) ▼|WFC85.57-1.61 (-1.85%) ▼|WMT113.10+1.56 (+1.40%) ▲|XOM140.95-0.75 (-0.53%) ▼|
30.4 C
New York
Wednesday, July 8, 2026

Tag: release

NativePath Liposomal Vitamin C: Urgent 2025 Consumer Warning on Why Most Vitamin C Pills May Fail — And the 3-in-1 Formula Positioned for Better...

Public interest in vitamin C has surged in 2025 as consumers search for cleaner, more effective options beyond standard pills. Across TikTok, Reddit, and wellness forums, questions are rising about ingredient sources, absorption rates, and the difference between synthetic ascorbic acid and real, whole-food vitamin C. NativePath Liposomal Vitamin C is positioned within this growing trend, featuring an amla-based 3-in-1 formula designed for nutrient integrity and advanced delivery. It reflects a broader shift toward transparency, clean sourcing, and solutions that align with evolving health and wellness priorities.
Public interest in vitamin C has surged in 2025 as consumers search for cleaner, more effective options beyond standard pills. Across TikTok, Reddit, and wellness forums, questions are rising about ingredient sources, absorption rates, and the difference between synthetic ascorbic acid and real, whole-food vitamin C. NativePath Liposomal Vitamin C is positioned within this growing trend, featuring an amla-based 3-in-1 formula designed for nutrient integrity and advanced delivery. It reflects a broader shift toward transparency, clean sourcing, and solutions that align with evolving health and wellness priorities.

Vertigenics – The Natural Vertigo Breakthrough Driving 2025 Interest in Balance and Brain Support Formulas

Public Interest in Natural Vertigo Support and Ingredient-First Balance Formulas Continues to Rise in 2025
Public Interest in Natural Vertigo Support and Ingredient-First Balance Formulas Continues to Rise in 2025

Acceleware Ltd. Announces Closing of Shares for Debt Transactions

CALGARY, Alberta, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of cutting-edge radio frequency (“RF”) power-to-heat technologies targeting process heat for critical minerals, amine regeneration (for carbon capture and other applications), and enhanced oil production, is pleased to announce that further to its news release dated June 30, 2025, the Company has closed certain shares for debt transactions to settle $186,337 in certain trades payable, management fees and interest payable on convertible debentures of the Company by issuing up to 1,863,375 Units at a deemed price of $0.10 per Unit (the “Shares for Debt Transactions”).

LungExpand Pro Gains 2025 Spotlight as Plant-Based Daily Support Formula Amid Rising Public Interest in Breathing Comfort and Respiratory Wellness

Growing interest in natural respiratory support draws attention to ingredient-first formulations like LungExpand Pro, blending plant extracts and nutrients often discussed for breathing comfort and daily lung health.
Growing interest in natural respiratory support draws attention to ingredient-first formulations like LungExpand Pro, blending plant extracts and nutrients often discussed for breathing comfort and daily lung health.

ROK Financial Streamlines Equipment Financing from $10,000 to $5 Million for All Industries

Fast, flexible funding options help businesses nationwide acquire essential equipment while preserving cash flow and supporting long-term growth.
Fast, flexible funding options help businesses nationwide acquire essential equipment while preserving cash flow and supporting long-term growth.

PUBMATIC ALERT: Bragar Eagel & Squire, P.C. is Investigating PubMatic, Inc. on Behalf of PubMatic Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PubMatic (PUBM) To Contact Him Directly To Discuss Their Options

APPLIED GRAPHITE GRANTS OPTIONS

VANCOUVER, BC, Aug. 13, 2025 /CNW/ - Applied Graphite Technologies Corporation ("AGT"), (TSXV: AGT) has granted 2,350,000 stock options at an exercise price of...

Northland Power Reports Second Quarter 2025 Results

TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland” or the “Company”) (TSX: NPI) today reported financial results for the three and six months ended June 30, 2025. All dollar amounts set out herein are in thousands of Canadian dollars, unless otherwise stated.

GERON (GERN) ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Geron Corporation (NASDAQ: GERN) on behalf of long-term stockholders following a class action complaint that was filed against Geron on March 14, 2025 with a Class Period from February 28, 2024 to February 25, 2025. Our investigation concerns whether the board of directors of Geron have breached their fiduciary duties to the company.

Old National Bancorp Announces Quarterly Dividends

EVANSVILLE, Ind., Aug. 13, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ONB) Old National Bancorp (the “Company” or “Old National”) today announced that its Board of Directors declared a quarterly cash dividend of $0.14 per share on the Company’s outstanding shares of common stock. This quarterly cash dividend will be payable on September 15, 2025, to shareholders of record as of the close of business on September 5, 2025.

Nuclear Fuels Shareholders Approve Arrangement with Premier American Uranium

CSE:NFOTCQX:NFUNF TSXV:PUR OTCQB:PAUIF VANCOUVER, BC, Aug. 13, 2025 /PRNewswire/ - Nuclear Fuels Inc. ("Nuclear Fuels" or the "Company") (CSE: NF) (OTCQX: NFUNF) and Premier American Uranium...

Nuclear Fuels Shareholders Approve Arrangement with Premier American Uranium

CSE:NFOTCQX:NFUNF TSXV:PUR OTCQB:PAUIF VANCOUVER, BC, Aug. 13, 2025 /CNW/ - Nuclear Fuels Inc. ("Nuclear Fuels" or the "Company") (CSE: NF) (OTCQX: NFUNF) and Premier American Uranium...

VitalHub Corp. Announces $65 Million Bought Deal Public Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, Aug. 13, 2025 /CNW/ - VitalHub Corp. (the "Company" or...

Neuro Sharp Gains Recognition in 2025 as Your Ultimate Brain Enhancement Formula

Scientifically Formulated Nootropic Backed by 2025 Research for Sharper Focus and Cognitive Support
Scientifically Formulated Nootropic Backed by 2025 Research for Sharper Focus and Cognitive Support

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRelease